EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Systematic Review of Participant Sex, Race, and Ethnicity Reporting in Interstitial Lung Disease Clinical Trials

Jackie Lin, Genevieve Gillett, Martin Ieong, Benjamin Aronson, Dylan Douglas, Timothy Dyster, Suresh Garudadri, Layne Keating, Ayodeji Adegunsoye, Erica Farrand

CHEST · 2026-08 · 170 (2) · 457-466

DOI: 10.1016/j.chest.2026.02.041 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift CHEST, 2026-08. Verfasst von Jackie Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, UCSF, San Francisco, CA. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Ethnicity, Lung Diseases, Interstitial, Patient Selection. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Heart Lung and Blood Institute, National Institutes of Health, Doris Duke Charitable Foundation Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Improving the generalizability of interstitial lung disease (ILD) research requires inclusion of diverse populations in clinical trials. Despite ongoing efforts to improve racial and ethnic minority participation, reporting and representation of sex, race, and ethnicity in ILD studies remain suboptimally defined. This systematic review evaluated demographic reporting and participant representation in ILD clinical trials. RESEARCH QUESTION What is the current state of sex, race, and ethnicity reporting and representation in ILD clinical trials, and what strategies are being implemented to enhance diversity and generalizability? STUDY DESIGN AND METHODS We systematically searched PubMed, Embase, and Web of Science for ILD clinical trials published in English between 2013 and 2023. Eligible studies were original research and enrolled adults with sample sizes 310. Standardized data abstraction captured study characteristics, recruitment strategies, and participant demographics. Descriptive statistics and multivariable regression assessed associations between study characteristics and both demographic reporting and enrollment diversity. RESULTS Among 241 included studies, sex was reported in 94%, whereas race and ethnicity were reported in only 27% and 8%, respectively. Race and ethnicity reporting showed nonsignificant upward trends; sex was more likely to be reported after 2018 (adjusted OR [aOR], 14.2; P < .01). Inclusion of US participants was the sole factor significantly associated with reporting race (aOR, 13.0; P < .01) and ethnicity (aOR, 12.9; P < .01). Among 70 US-enrolling studies, Asian participants were overrepresented relative to a national ILD registry, whereas Black and Hispanic/Latino participants were underrepresented. No studies reported using non-English recruitment materials; 1 study reported patient navigation or coaching. INTERPRETATION Our results show that this systematic review delineates the current state of participant demographics in ILD clinical trials, establishing a critical benchmark for future recruitment efforts. The frequent omission of race and ethnicity data despite consistent sex data underscores a need for standardized demographic reporting and intentional strategies to enhance the diversity and generalizability of ILD trials. CLINICAL TRIAL REGISTRATION PROSPERO; No.: 1057947; URL: https://www.crd.york.ac.uk/prospero/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicEthnicityLung Diseases, InterstitialPatient SelectionRacial GroupsHumansSex Factors

Stichwörter der Autor:innen

clinical trialshealth equityinterstitial lung diseaseparticipant demographicsrace and ethnicityrecruitment strategies

Autor:innen und Institutionen

  • Department of Medicine, UCSF, San Francisco, CA.
  • Department of Medicine, Division of Pulmonary & Critical Care Medicine, UCSF, San Francisco, CA.
  • Department of Medicine, University of Chicago, Chicago, IL.
  • Pulmonary & Critical Care Medicine, University of Chicago, Chicago, IL.
  • Department of Medicine, Division of Pulmonary & Critical Care Medicine, UCSF, San Francisco, CA. Electronic address: Erica.farrand@ucsf.edu.

Förderung

  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • Doris Duke Charitable Foundation Inc

Zitieren

APA

Lin, J., Gillett, G., Ieong, M., Aronson, B., Douglas, D., Dyster, T., Garudadri, S., Keating, L., Adegunsoye, A., & Farrand, E. (2026). Systematic Review of Participant Sex, Race, and Ethnicity Reporting in Interstitial Lung Disease Clinical Trials. CHEST, 170(2), 457-466. https://doi.org/10.1016/j.chest.2026.02.041

Vancouver

Lin J, Gillett G, Ieong M, Aronson B, Douglas D, Dyster T, et al. Systematic Review of Participant Sex, Race, and Ethnicity Reporting in Interstitial Lung Disease Clinical Trials. CHEST. 2026;170(2):457-466. doi:10.1016/j.chest.2026.02.041

BibTeX
@article{Lin2026,
  author = {Lin, Jackie and Gillett, Genevieve and Ieong, Martin and Aronson, Benjamin and Douglas, Dylan and Dyster, Timothy and Garudadri, Suresh and Keating, Layne and Adegunsoye, Ayodeji and Farrand, Erica},
  title = {Systematic Review of Participant Sex, Race, and Ethnicity Reporting in Interstitial Lung Disease Clinical Trials},
  journal = {CHEST},
  year = {2026},
  volume = {170},
  number = {2},
  pages = {457--466},
  doi = {10.1016/j.chest.2026.02.041}
}
Kostenlos starten →